DAISY- Diagnostic AI System for Robotic and Automated Triage and Assessment (DAISY)

DAISY: Diagnostic AI System for Robotic and Automated Triage and Assessment

This study aims to introduce an automated triaging system called DAISY into the Emergency Department (ED) to give patients the opportunity to self-direct their initial consultation. This is a new system in development, with a robot like the image at the top of this sheet, a touchscreen that will ask patients a number of questions about their current health (as a Triage nurse or doctor in the Emergency Department may do) but also with some attached devices (like a blood pressure monitor and thermometer) that patients can use to help DAISY assess patients' current health.

This study aims to demonstrate how patients can interact with the automated system to produce a report that is useful for the doctors and nurses in the ED. The study will examine the duration and timeliness of the automated assessment to see if it frees up staff time and determine how patients find the experience of using the DAISY system.

Study Overview

• Status: Completed
• Conditions: Emergencies
• Intervention / Treatment: Device: DAISY system

Detailed Description

The number of patients arriving at Emergency Departments (EDs) in England increased by 21% between 2010 and 2019. Combined with international healthcare staff shortages which have been an ongoing concern for over three decades, this has resulted in overcrowded EDs and long patient waits. Over 20,000 patients waited more than 12 hours for treatment in EDs in England in December 2021. As such, solutions must be explored to alleviate the strain on medical professionals and systems so that they can optimise their time,and increase the throughput in EDs for the benefit of patients.

The use of digital technology to collect, organise and perform initial analysis of patients without the need to interact with healthcare staff, theoretically frees staff from data collection, reducing waiting times and the door-to-treatment times. DAISY is a proposed humanoid Robot that uses digital technology to perform these 'front-door' functions.

The trial participants will be patients who self-present to the Emergency Department with acute clinical needs. The study is unblinded and adult ED users are invited to participate in the use of an automated triage process while they await the regular human triage personnel. Potential participants may be primarily identified by the reception staff after which they undergo an initial screening by a member of the investigating team who consents the patient for the study according to the protocol specifications. The participants, thereafter interact with DAISY to complete a consultation after which an anonymised report is generated as the initial Case Report Form (CRF). The participant returns to their original position in the traditional triage queue without an advantage or disadvantage in the 'time-to-see' a clinician. Their return signifies the end of their active participation in the trial.

Participants are expected to spend less than 30 minutes for the automated consultation. They may choose to discontinue their engagement with the study at any point during the process. Participants who do not complete the process will be included in the final data analysis.

• Study Type: Observational
• Enrollment (Actual): 156

Contacts and Locations

Study Locations

• United Kingdom
  • N. Yorks
    • York, N. Yorks, United Kingdom, YO31 8HE
      • York & Scarborough Teaching Hospitals NHS Foundation Trust

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

All patients over 18 years of age attending the Emergency Department

Description

Inclusion Criteria:

• Willing and able to give informed consent
• Aged 18 years or above
• Able and willing to comply with all study requirements
• Able to engage or operate the automated system, either unaided or with help from own carers

Exclusion Criteria:

• Less than 18 years of age
• Decreased consciousness and/or affect
• In need of urgent transfer to the resuscitation area
• Deemed unsuitable or too unwell by the recruiting investigator

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Acceptability	Patient feedback scores	30 minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Duration	Time taken for the consultation process	30 minutes
Engagement	Patient satisfaction scores with the automated process	30 minutes
Concordance	Level of concordance between DAISY report and human generated report	30 minutes

Collaborators and Investigators

• Sponsor: York Teaching Hospitals NHS Foundation Trust
• Collaborators: University of York

Study record dates

Study Major Dates

• Study Start (Actual): March 17, 2025
• Primary Completion (Actual): March 31, 2026
• Study Completion (Actual): March 31, 2026

Study Registration Dates

• First Submitted: August 16, 2024
• First Submitted That Met QC Criteria: August 22, 2024
• First Posted (Actual): August 26, 2024

Study Record Updates

• Last Update Posted (Actual): April 8, 2026
• Last Update Submitted That Met QC Criteria: April 2, 2026
• Last Verified: April 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Pathological Conditions, Signs and Symptoms; Emergencies
• Other Study ID Numbers: 343550

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No